Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease

A fixed-dose inhaled corticosteroid/long-acting β(2)-agonist (ICS/LABA) combination of extrafine beclometasone dipropionate and formoterol fumarate (BDP/FF) has been recently approved for use in chronic obstructive pulmonary disease (COPD). Small airway inflammation and remodelling are cardinal feat...

Full description

Saved in:
Bibliographic Details
Published in:NPJ Prim Care Respir Med
Main Authors: Singh, Dave, Corradi, Massimo, Spinola, Monica, Petruzzelli, Stefano, Papi, Alberto
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2016
Subjects:
Review Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910970/
https://ncbi.nlm.nih.gov/pubmed/27309985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjpcrm.2016.30
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items